Support for families grieving an overdose loss
Official title: Families Left Behind: Addressing Prolonged Grief and Substance Use Disorders Among People Bereaved by Drug Overdose Deaths
Run by Rand · NCT06854757 · Data updated 2026-11-12
This project will test a peer-led grief support program called RIVER to help adults who lost a loved one to an unintentional drug overdose within the past year.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 340 (estimated) |
| Sponsor | Rand Academic / other |
| Locations | 4 sites (Birmingham, Alabama and 3 other locations) |
| Status | Recruiting |
| Started | June 13, 2025 |
| Main results expected | August 29, 2026 |
| Study ends | October 2030 |
| Registry record updated | August 21, 2025 |
| Trial ID | NCT06854757 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 and older who fluently read English or Spanish, can give consent, and who lost a loved one to an unintentional drug overdose within the past year are the intended participants.
✕Probably not a fit
People with active suicidal ideation, those requiring psychiatric or substance-use hospitalization, anyone whose loss was more than one year ago, or whose loved one died by suicide or undetermined intent may not be appropriate or benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares a peer-delivered grief support program (RIVER) with enhanced care as usual for people bereaved by unintentional drug overdose. Participants are identified through collaborating medical examiner offices and work with Peer Support Community Partners alongside research teams from RAND and Stanford. Eligible adults (18+) who lost a loved one to an unintentional overdose within the past year and who can consent will be enrolled; people with active suicidal ideation or recent psychiatric hospitalization are excluded. Outcomes will include measures of prolonged grief, substance use, PTSD, depression, and related risk behaviors.
Why it matters
Potential benefit: If successful, the program could reduce prolonged grief symptoms and lower the risk of substance misuse and suicidal thoughts among people bereaved by overdose.
How similar studies have gone: Peer grief support interventions have shown promise in bereavement and behavioral health settings, but rigorous trials specifically targeting overdose bereavement remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * people who lost a loved one to an unintentional drug overdose death within the past year * age 18 and older * fluently understand English or Spanish * have the capacity to give consent (e.g., excluding those with severe cognitive impairment, those in active psychosis, and those with developmental disabilities). Exclusion Criteria: * people who need hospitalization for psychiatric symptoms or substance use disorders. (Note, people who use drugs but who do not require hospitalization will be included.) * people have active suicidal ideation * people who lost someone to a drug overdose death more than one year ago * people who lost someone to a drug overdose death that was suicidal in nature or of undetermined intent
Where it's running
-
Jefferson County Coroner/Medical Examiner's Office
Birmingham, Alabama, United States Recruiting -
San Diego County Medical Examiner Office
San Diego, California, United States Recruiting -
Connecticut Office of the Chief Medical Examiner
Farmington, Connecticut, United States Recruiting -
Peer Support Community Partners
Watertown, Massachusetts, United States Active not recruiting
Study contacts
- Principal investigator: Alison Athey, PhD — Rand
- Study coordinator: Alison Athey, PhD
- Email: aathey@rand.org
- Phone: (703) 413-1100
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Interprofessional Training to Improve Care for Peri-Delivery Patients with Substance Use Disorder
This program tests INSPIRE, a set of online and in-person trainings for healthcare teams to reduce stigma and improve care for people with substance use disorder around labor, delivery, and postpartum at the University of Utah.
-
Effects of comorbidity on people with severe mental illness
This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.
-
Interdisciplinary support to smooth care transitions for hospitalized adults with substance use disorders
This study tests a team-based in-hospital and post-discharge program to help adults with substance use disorders move from hospital care to ongoing community treatment.
-
Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice (MISSION-CJ) for re-entry
This trial tests a multicomponent program called MISSION-CJ with Peer Linkage Support to help adults released from two Massachusetts jails who have both mental health and substance use disorders.
-
Helping toddlers of caregivers with substance use disorders build language skills with group and individualized parenting supports
This project will test whether adding coaching and one-on-one lessons to a group parenting program helps toddlers (12–42 months) of caregivers with substance use disorders develop better language skills.
-
Recovery Inspired Support Engagement: A 12‑week 1-on-1 program for families and friends supporting someone in recovery
A 12‑week telehealth program will test whether a one‑on‑one support program for people who support loved ones in substance use recovery is doable and acceptable.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.